IMPACT BIOMEDICAL INC
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
IBO$4.33+5.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
Impact BioMedical, Inc. and Subsidiaries
Consolidated Statements of Changes in Stockholders’ Equity
| Common Stock · Preferred Stock · Additional Paid-in · Accumulated · Non- controlling Interest in | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Deficit · Subsidiary · Total | |||||||||
| Balance, December 31, 2021 | 70,496,041 | $70,000 | - | $ | - | $38,113,000 | $(1,574,000) | $3,315,000 | $39,924,000 |
| Net loss | - | - | - | - | - | (7,051,000) | (204,000) | (7,255,000) | |
| Balance, December 31, 2022 | 70,496,041 | $70,000 | - | $ | - | $38,113,000 | $(8,625,000) | $3,111,000 | $32,669,000 |
| Conversion of common stock to preferred stock | (60,496,041) | (60,000) | 60,496,041 | 60,000 | - | - | - | - | |
| Net loss | - | - | - | - | - | (4,336,000) | (71,000) | (4,407,000) | |
| Balance, December 31, 2023 | 10,000,041 | $10,000 | 60,496,041 | $60,000 | $38,113,000 | $(12,961,000) | $3,040,000 | $28,262,000 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.